Investor Alert: Kaplan Fox Announces Investigation Of Synergy Pharmaceuticals Inc.

February 24, 2018

Responsive image

NEW YORK, Feb. 24, 2018 /PRNewswire/ — Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Synergy Pharmaceuticals Inc. (“Synergy” or the “Company”) (NASDAQ: SGYP).  Investors who purchased Synergy securities between September 5, 2017 and…

Category: Precious Metals